Aprea Therapeutics, Inc. (APRE) Free cash flow 2019–2025
Aprea Therapeutics, Inc. (APRE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.9MFY2025 · since FY2019: -$26.7M → -$12.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.9M | +5.4% |
| FY2024 | -$13.6M | — |
| FY2021 | -$37.7M | +9.9% |
| FY2020 | -$41.8M | -56.6% |
| FY2019 | -$26.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice